Timing and Timeliness in Medical Care Evaluation
- 1 March 1996
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 9 (3) , 183-187
- https://doi.org/10.2165/00019053-199609030-00001
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- The Tension Between Cost Containment and the Underutilization of Effective Health ServicesInternational Journal of Technology Assessment in Health Care, 1996
- A Comparative Review of Pharmacoeconomic GuidelinesPharmacoEconomics, 1995
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- A Reappraisal of Hepatitis B Virus Vaccination Strategies Using Cost-Effectiveness AnalysisAnnals of Internal Medicine, 1993
- Cost and Quality Effects of Alternative Treatments for Persistent Gastroesophageal Reflux DiseaseArchives of internal medicine (1960), 1992
- Issues in Mandatory Economic Assessment of PharmaceuticalsHealth Affairs, 1992
- Cost-effectiveness of HA-1A monoclonal antibody for gram-negative sepsis. Economic assessment of a new therapeutic agent.1991
- Abruptly Changing Patterns of Diffusion and Use of Extracorporeal Shock-wave Renal LithotripsyAmerican Journal of Kidney Diseases, 1991
- Indications for Use of Hepatitis B Vaccine, Based on Cost-Effectiveness AnalysisNew England Journal of Medicine, 1982
- The historical development of clinical therapeutic trialsJournal of Chronic Diseases, 1959